advertising
-
1
Buchan W: Domestic Medicine: A Treatise on the Prevention and Cure of Disease by Regimen and Simple Medicines, p 1, Strahan, London, 1794..
-
2
Showalter E: The Female Malady: Women, Madness, and English Culture, 1830-1980, p 1, Virago, London, 1987..
-
3
McPherson A, Waller D (eds): Women’s Health, 4th Ed, p 1, Oxford University Press, Oxford, 1997..
-
4
Cameron ST, Critchley HO, Glasier AF, et al: Continuous transdermal estrogen and interrupted progestin as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women. .Br J Obstet Gynaecol 104::1184. ,1997. .
-
5
Hardy R, Kuh D: Reproductive characteristics and the age at inception of the perimenopause in a British National Cohort. .Am J Epidemiol 149::612. ,1999. .
-
6
Khaw KT: Epidemiology of the menopause. .Br Med Bull 48::249. ,1992. .
-
7
Cresswell JL, Egger P, Fall CH, et al: Is the age of menopause determined in-utero. ?Early Hum Dev 49::143. ,1997. .
-
8
Hunter M: The south-east England longitudinal study of the climacteric and postmenopause. .Maturitas 14::117. ,1992. .
-
9
Hunter MS, Liao KL: A psychological analysis of menopausal hot flushes. .Br J Psychol 34: (pt 4):589. ,1995. .
-
10
Klein P, Versi E, Herzog A: Mood and the menopause. .Br J Obstet Gynaecol 106::1. ,1999. .
-
11
Chenoy R, Hussain S, Tayob Y, et al: Effect of oral gamolenic acid from evening primrose oil on menopause flushing. .BMJ 308::501. ,1994. .
-
12
Daly E, Gray A, Barlow D, et al: Measuring the impact of menopausal symptoms on quality of life. .BMJ 307::836. ,1993. .
-
13
Studd JW, Watson NR, Montgomery J: Depression and the menopause. .BMJ 300::1653. ,1990. .
-
14
Porter M, Penney GC, Russell D, et al: A population based survey of women’s experience of the menopause. .Br J Obstet Gynaecol 103::1025. ,1996. .
-
15
Greendale GA, Lee NP, Arriola ER: The menopause. .Lancet 353::571. ,1999. .
-
16
Office for National Statistics: Mortality Statistics: Cause 1993 (revised) and 1994, DH2 no 21, Her Majesty’s Stationery Office, London, 1996..
-
17
van der Schouw YT, van der Graaf Y, Steyerberg EW, et al: Age at menopause as a risk factor for cardiovascular mortality. .Lancet 347::714. ,1996. .
-
18
Stevenson JC: Metabolic effects of the menopause and estrogen replacement. .Baillieres Clin Obstet Gynaecol 10::449. ,1996. .
-
19
Johnell O: Prevention of fractures in the elderly: a review. .Acta Orthop Scand 66::90. ,1995. .
-
20
Ettinger B, Pressman A, Sklarin P, et al: Associations between low levels of serum cholesterol, bone density, and fractures among elderly women: the study of osteoporotic fractures. .J Clin Endocrinol Metab 83::2239. ,1998. .
-
21
Tucci JR: Osteoporosis update. .Med Health RI 81::169. ,1998. .
-
22
Morse CA, Smith A, Dennerstein L, et al: The treatment-seeking woman at menopause. .Maturitas 18::61. ,1994. .
-
23
Dempster DW, Lindsay R: Pathogenesis of osteoporosis. .Lancet 341::797. ,1993. .
-
24
Rickard DJ, Subramaniam M, Spelsberg TC: Molecular and cellular mechanisms of estrogen action on the skeleton. .J Cell Biochem 32/33: (suppl):123. ,1999. .
-
25
Takahashi M, Kushida K, Hoshino H, et al: Biochemical markers of bone turnover do not decline after menopause in healthy women. .Br J Obstet Gynaecol 106::427. ,1999. .
-
26
Cummings SR, Nevitt MC, Browner WS, et al: Risk factors for hip fractures in white women. Study of Osteoporotic Fractures Research Group. .N Engl J Med 332::767. ,1995. .
-
27
Kanis JA, McCloskey EV: Risk factors in osteoporosis. .Maturitas 30::229. ,1998. .
-
28
Freeman D, Randall DB: Stress fracture of the foot secondary to osteoporosis: an atypical presentation. .JAPMA 91::99. ,2001. .
-
29
Spector TD, Keen RW, Arden NK, et al: Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. .BMJ 310::1357. ,1995. .
-
30
Cooper C, Atkinson EJ, Jacobsen SJ, et al: Population-based study of survival after osteoporotic fractures. .Am J Epidemiol 137::1001. ,1993. .
-
31
Seeley DG, Browner WS, Nevitt MC, et al: Which fractures are associated with low appendicular bone mass in elderly women. ?Ann Intern Med 115::837. ,1991. .
-
32
Varenna M, Binelli L, Zucchi F, et al: Is the metatarsal fracture in postmenopausal women an osteoporotic fracture? A cross-sectional study on 113 cases. .Osteoporos Int 7::558. ,1997. .
-
33
Honkanen R, Tuppurainen M, Kröger H, et al: Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. .Osteoporos Int 8::25. ,1998. .
-
34
Kröger H, Huopio J, Honkanen R, et al: Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. .J Bone Miner Res 10::302. ,1995. .
-
35
Nguyen T, Sambrook P, Kelly P, et al: Prediction of osteoporotic fractures by postural instability and bone density. .BMJ 307::1111. ,1993. .
-
36
Kaye RA: Insufficiency stress fractures of the foot and ankle in postmenopausal women. .Foot Ankle Int 19::221. ,1998. .
-
37
Santi M, Sartoris DJ: Diagnostic imaging approach to stress fractures of the foot. .J Foot Surg 30::90. ,1991. .
-
38
Resnick D, Georgen TG, Niwayama G: “Physical Injury: Concepts and Terminology,” in Diagnosis of Bone and Joint Disorders, 3rd Ed, ed by D Resnick, p 2561, WB Saunders, Philadelphia, 1995..
-
39
Tomezak RL, Van Court R: Metatarsal insufficiency fractures in previously underdiagnosed osteoporosis patients. .J Foot Ankle Surg 39::174. ,2000. .
-
40
Lichniak JE: The heel in systemic disease. .Clin Podiatr Med Surg 7::225. ,1990. .
-
41
Christman RA: A systematic approach for radiographically evaluating joint disease in the foot. .JAPMA 81::174. ,1991. .
-
42
Aggarwal ND, Singh GD, Aggarwal R, et al: A survey of osteoporosis using the calcaneum as an index. .Int Orthop 10::147. ,1986. .
-
43
Ettinger B, Friedman GD, Bush T, et al: Reduced mortality associated with long-term menopausal estrogen therapy. .Obstet Gynecol 87::6. ,1996. .
-
44
Hunt V, Vessey M, McPherson K: Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. .Br J Obstet Gynaecol 97::1080. ,1990. .
-
45
British Medical Association and Royal Pharmaceutical Society of Great Britain: British National Formulary, 40th Ed, p 337, BMA and The Pharmaceutical Press, London, 2000..
-
46
Cutson TM, Meuleman E: Managing menopause. .Am Fam Physician 61::1391. ,2000. .
-
47
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. .Lancet 350::1047. ,1997. .
-
48
Stallard S, Litherland JC, Cordiner CM, et al: Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study. .BMJ 320::348. ,2000. .
-
49
Voight LF, Weiss NS, Chu J, et al: Progestagen supplementation of exogenous estrogens and risk of endometrial cancer. .Lancet 338::274. ,1991. .
-
50
Cameron IT, Fraser IS, Smith SK: Clinical Disorders of the Endometrium and Menstrual Cycle, p 1, Oxford University Press, Oxford, 1997..
-
51
Delmas PD, Bjarnason NH, Mitlak BH, et al: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. .N Engl J Med 337::1641. ,1997. .
-
52
Plouffe L Jr: Selective estrogen receptor modulators (SERMs) in clinical practice. .J Soc Gynecol Investig 7: (suppl 1):S38. ,2000. .
-
53
Bryant HU, Dere WH: Selective estrogen modulators: an alternative to hormone replacement therapy. .Proc Soc Exp Biol Med 217::45. ,1998. .
-
54
Delmas PD: Clinical use of selective estrogen receptor modulators. .Bone 25::115. ,1999. .
-
55
Ulrich LG, Barlow DH, Sturdee DW, et al: Quality of life and patient preference for sequential versus continuous combined hormone replacement therapy: the US Kliofem multicenter study experience. .Int J Gynaecol Obstet 59: (suppl 1):S11. ,1997. .
-
56
Genazzani AR, Spinetti A, Gallo R, et al: Menopause and the central nervous system: intervention options. .Maturitas 31::103. ,1999. .
-
57
Medical Research Council’s General Practice Research Framework: Randomized comparison of estrogen versus estrogen plus progestin hormone replacement therapy in women with hysterectomy. .BMJ 312::473. ,1996. .
-
58
Mijatovic V, Kenemans P, Netelenbos JC, et al: Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women. .J Clin Endocrinol Metab 82::3543. ,1997. .
-
59
Herrington DM, Reboussin DM, Brosnihan KB, et al: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. .N Engl J Med 343::522. ,2000. .
-
60
Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. .JAMA 280::605. ,1998. .
-
61
Writing Group for the Women’s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. .JAMA 288::321. ,2002. .
-
62
Fogelman I: The effects of estrogen deficiency on the skeleton and its prevention. .Br J Obstet Gynaecol 103: (suppl 14):5. ,1996. .
-
63
Michaelsson K, Baron JA, Farahmand BY, et al: Hormone replacement therapy and risk of hip fracture: population based case-control study. .BMJ 316::1858. ,1998. .
-
64
Rizzoli R, Bonjour JP: Hormones and bones. .Lancet 349: (suppl 1):20. ,1997. .
-
65
Devine A, Dick IM, Heal SJ, et al: A four year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. .Osteoporos Int 7::23. ,1997. .
-
66
Lindsay R: The menopause and osteoporosis. .Obstet Gynecol 87: (suppl 2):16S. ,1996. .
-
67
Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin intervention (PEPI) Trial. .JAMA 276::1389. ,1996. .
The Biology, Medical Management, and Podiatric Implications of Menopause
Search for other papers by Arthur H. Friedlander in
Current site
Google Scholar
PubMed
Search for other papers by Lester J. Jones in
Current site
Google Scholar
PubMed
Approximately 36 million women in the United States are in the postmenopausal phase of life, creating unique challenges for the provision of compassionate, comprehensive podiatric medical treatment. Long-term estrogen deprivation arising from menopause in association with age-related factors disproportionately increases the risk of ischemic heart disease, osteoporosis, and concomitant podiatric complications. This article discusses the physiologic basis of menopause, hormone replacement therapy and its effects on osteoporosis, and other podiatric implications of menopause. Podiatric physicians caring for larger numbers of peri- and postmenopausal women must formulate a comprehensive management plan for treating fractures that arise from a combination of estrogen-deprivation osteoporosis and abnormal foot biomechanics. (J Am Podiatr Med Assoc 92(8): 437-443, 2002)
advertising
